Trials / Terminated
TerminatedNCT01572610
A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
A Phase 2 GFR Measuring Study of RTA 402 in CKD Patients With Type 2 Diabetes Mellitus
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
A Phase 2 glomerular filtration rate (GFR) measuring study of RTA 402 in Chronic kidney disease (CKD) patients with type 2 diabetes mellitus.
Detailed description
An exploratory study to investigate the effects of RTA 402 on glomerular filtration rate in CKD patients with type 2 diabetes mellitus. To evaluate the safety of RTA 402.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RTA 402 | once a day, oral administration |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2012-04-06
- Last updated
- 2017-03-03
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01572610. Inclusion in this directory is not an endorsement.